Literature DB >> 7197718

Binding of drugs to human serum albumin XVII: Irreversible binding of mercaptopurine to human serum proteins.

I Sjöholm, B Stjerna.   

Abstract

Studies on the binding of mercaptopurine to human serum, human serum albumin or orosomucoid gave varying results, with binding ranging from 20 to 90%. Binding has been shown to be affected by oxidizing agents, which increase binding at low concentrations, and by reducing agents, which decrease binding. Repeated equilibrium dialyses and gel filtration experiments indicated that mercaptopurine is partly irreversibly bound to serum proteins. This binding is oxidation dependent and probably involves the sulfhydryl group of the drug.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197718     DOI: 10.1002/jps.2600701130

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  The investigation of the binding of 6-mercaptopurine to site I on human serum albumin.

Authors:  Jolanta Sochacka; Wojciech Baran
Journal:  Protein J       Date:  2012-12       Impact factor: 2.371

2.  Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia.

Authors:  C A Rees; L Lennard; J S Lilleyman; J L Maddocks
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

3.  Impact of anti-cancer drugs and other determinants on serum protein binding of morphine 6-glucuronide.

Authors:  S O Mashayekhi; M Ghandforoush-Sattari; D C Buss; P A Routledge; R Dw Hain
Journal:  Daru       Date:  2010       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.